نتایج جستجو برای: col6a2

تعداد نتایج: 61  

Journal: :The Journal of clinical investigation 2015
Rodolphe Soret Mathilde Mennetrey Karl F Bergeron Anne Dariel Michel Neunlist Franziska Grunder Christophe Faure David W Silversides Nicolas Pilon

Hirschsprung's disease (HSCR) is a severe congenital anomaly of the enteric nervous system (ENS) characterized by functional intestinal obstruction due to a lack of intrinsic innervation in the distal bowel. Distal innervation deficiency results from incomplete colonization of the bowel by enteric neural crest cells (eNCCs), the ENS precursors. Here, we report the generation of a mouse model fo...

2016
Jessica C. de Greef Rebecca Hamlyn Braden S. Jensen Raul O'Campo Landa Jennifer R. Levy Kazuhiro Kobuke Kevin P. Campbell

Muscular dystrophy is characterized by progressive skeletal muscle weakness and dystrophic muscle exhibits degeneration and regeneration of muscle cells, inflammation and fibrosis. Skeletal muscle fibrosis is an excessive deposition of components of the extracellular matrix including an accumulation of Collagen VI. We hypothesized that a reduction of Collagen VI in a muscular dystrophy model th...

Journal: :Anesthesiology 2021

I read with great interest the short report published in Images Anesthesiology section about difficult intubation a 2-yr-old patient Ullrich congenital muscular dystrophy.1 This disease is well known to carry risk of intubation.2–6 The authors nicely described how they used nasopharyngeal airway administer volatile anesthetic and oxygen through one nostril while performing nasotracheal fiberopt...

2014
Sandra Lettmann Wilhelm Bloch Tobias Maaß Anja Niehoff Jan-Niklas Schulz Beate Eckes Sabine A. Eming Paolo Bonaldo Mats Paulsson Raimund Wagener

Patients suffering from collagen VI related myopathies caused by mutations in COL6A1, COL6A2 and COL6A3 often also display skin abnormalities, like formation of keloids or "cigarette paper" scars, dry skin, striae rubrae and keratosis pilaris (follicular keratosis). Here we evaluated if Col6a1 null mice, an established animal model for the muscle changes in collagen VI related myopathies, are a...

2014
Nicholas Nissen Dong-Joo Cheon

The standard of care for ovarian cancer is aggressive cytoreductive surgery followed by chemotherapy with platinum and taxane. Despite initial favorable responses, 65 percent of these patients recur with chemoresistant cancer during the first three years and succumb to disease. Currently, there is no diagnostic tool that identifies patients who have a high likelihood of recurrence, and treatmen...

2014
A Reghan Foley Robert D S Pitceathly Jie He Jihee Kim Nathaniel M Pearson Francesco Muntoni Michael G Hanna

BACKGROUND Clinicians are faced with unprecedented opportunities to identify the genetic aetiologies of hitherto molecularly uncharacterised conditions via the use of high-throughput sequencing. Access to genomic technology and resultant data is no longer limited to clinicians, geneticists and bioinformaticians, however; ongoing commercialisation gives patients themselves ever greater access to...

2016
Francesca Sardone Francesco Traina Alice Bondi Luciano Merlini Spartaco Santi Nadir Mario Maraldi Cesare Faldini Patrizia Sabatelli

Collagen VI (COLVI) is a non-fibrillar collagen expressed in skeletal muscle and most connective tissues. Mutations in COLVI genes cause two major clinical forms, Bethlem myopathy and Ullrich congenital muscular dystrophy (UCMD). In addition to congenital muscle weakness, patients affected by COLVI myopathies show axial and proximal joint contractures and distal joint hypermobility, which sugge...

2014
Satoru Noguchi Megumu Ogawa Genri Kawahara May Christine Malicdan Ichizo Nishino

Ullrich congenital muscular dystrophy (UCMD) is an inherited muscle disorder characterized clinically by muscle weakness, distal joint hyperlaxity, and proximal joint contractures. Sporadic and recessive mutations in the three collagen VI genes, COL6A1, COL6A2, and COL6A3, are reported to be causative. In the sporadic forms, a heterozygous point mutation causing glycine substitution in the trip...

Journal: :Blood 2011
Laura E Hogan Julia A Meyer Jun Yang Jinhua Wang Nicholas Wong Wenjian Yang Gregory Condos Stephen P Hunger Elizabeth Raetz Richard Saffery Mary V Relling Deepa Bhojwani Debra J Morrison William L Carroll

Despite an increase in survival for children with acute lymphoblastic leukemia (ALL), the outcome after relapse is poor. To understand the genetic events that contribute to relapse and chemoresistance and identify novel targets of therapy, 3 high-throughput assays were used to identify genetic and epigenetic changes at relapse. Using matched diagnosis/relapse bone marrow samples from children w...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید